HFS
GILD icon

Hantz Financial Services’s Gilead Sciences GILD Stock Holding History

Hantz Financial Services’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.4M Sell
26,884
-492
-2% -$64.8K 0.05% 256
2026
Q1 		$3.81M Buy
27,376
+383
+1% +$53.6K 0.06% 226
2025
Q4 		$3.31M Sell
26,993
-167
-0.6% -$20.3K 0.05% 247
2025
Q3 		$3.02M Sell
27,160
-883
-3% -$100K 0.05% 268
2025
Q2 		$3.11M Sell
28,043
-1,080
-4% -$115K 0.05% 268
2025
Q1 		$3.26M Sell
29,123
-34,443
-54% -$3.55M 0.06% 259
2024
Q4 		$5.87M Sell
63,566
-7,260
-10% -$654K 0.1% 195
2024
Q3 		$5.94M Sell
70,826
-2,422
-3% -$185K 0.11% 197
2024
Q2 		$5.03M Sell
73,248
-4,224
-5% -$282K 0.1% 207
2024
Q1 		$5.67M Sell
77,472
-26,653
-26% -$2.05M 0.11% 200
2023
Q4 		$8.44M Sell
104,125
-6,026
-5% -$469K 0.18% 161
2023
Q3 		$8.26M Buy
110,151
+42,979
+64% +$3.31M 0.21% 144
2023
Q2 		$5.18M Buy
67,172
+400
+0.6% +$31.9K 0.13% 193
2023
Q1 		$5.54M Buy
66,772
+1,063
+2% +$88K 0.15% 177
2022
Q4 		$5.64M Buy
65,709
+2,903
+5% +$230K 0.17% 169
2022
Q3 		$3.87M Buy
62,806
+1,586
+3% +$100K 0.13% 195
2022
Q2 		$3.78M Buy
61,220
+2,701
+5% +$167K 0.13% 197
2022
Q1 		$3.48M Buy
58,519
+3,906
+7% +$250K 0.1% 220
2021
Q4 		$3.96M Buy
54,613
+3,117
+6% +$215K 0.11% 197
2021
Q3 		$3.6M Buy
51,496
+5,805
+13% +$408K 0.12% 197
2021
Q2 		$3.15M Buy
45,691
+3,343
+8% +$223K 0.12% 200
2021
Q1 		$2.74M Buy
42,348
+533
+1% +$34.4K 0.11% 209
2020
Q4 		$2.44M Buy
41,815
+270
+0.6% +$16.3K 0.11% 207
2020
Q3 		$2.63M Sell
41,545
-576
-1% -$39.9K 0.13% 189
2020
Q2 		$3.24M Buy
42,121
+770
+2% +$59K 0.18% 166
2020
Q1 		$3.09M Buy
+41,351
New +$2.86M 0.21% 148

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hantz Financial Services's GILD Position: Q2 2026 in Review

Hantz Financial Services reduced its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, selling an estimated $64.8K and leaving 26,884 shares worth $3.4M. The position accounts for 0.05% of the portfolio, ranked #256.

Hantz Financial Services first reported a position in GILD in Q1 2020 and has held it in 26 quarters since. The position peaked at $8.44M in Q4 2023. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hantz Financial Services held 26,884 shares of Gilead Sciences worth $3.4M as of Q2 2026.
  • Hantz Financial Services sold 492 Gilead Sciences shares in Q2 2026, an estimated $64.8K.
  • Gilead Sciences made up 0.05% of Hantz Financial Services's portfolio in Q2 2026, its #256 holding.
  • Hantz Financial Services first reported a position in Gilead Sciences in Q1 2020 and has held it in 26 quarters since.
  • Hantz Financial Services's Gilead Sciences position peaked at $8.44M in Q4 2023.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.